KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Sales (2016 - 2025)

Historic Return on Sales for TherapeuticsMD (TXMD) over the last 16 years, with Q3 2025 value amounting to 0.13%.

  • TherapeuticsMD's Return on Sales rose 2100.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year decrease of 3300.0%. This contributed to the annual value of 0.07% for FY2024, which is 20600.0% up from last year.
  • Latest data reveals that TherapeuticsMD reported Return on Sales of 0.13% as of Q3 2025, which was up 2100.0% from 0.01% recorded in Q2 2025.
  • TherapeuticsMD's Return on Sales' 5-year high stood at 365.39% during Q2 2022, with a 5-year trough of 44.81% in Q1 2022.
  • Its 5-year average for Return on Sales is 12.61%, with a median of 0.04% in 2025.
  • Its Return on Sales has fluctuated over the past 5 years, first skyrocketed by 3672400bps in 2022, then plummeted by -3651900bps in 2023.
  • TherapeuticsMD's Return on Sales (Quarter) stood at 2.68% in 2021, then tumbled by -84bps to 0.43% in 2022, then surged by 207bps to 1.31% in 2023, then plummeted by -84bps to 0.21% in 2024, then plummeted by -37bps to 0.13% in 2025.
  • Its Return on Sales was 0.13% in Q3 2025, compared to 0.01% in Q2 2025 and 0.04% in Q1 2025.